News for EKF Diagnostics Holdings plc (EKDHF)

Revolutionizing Healthcare: The Urinalysis Market Expected to Expand from $4.28 Billion in 2023 to an Impressive $8.97 Billion by 2031, Achieving a Robust...

The cardiac marker testing market is driven by the rising prevalence of cardiovascular diseases, increasing awareness of early diagnosis, and advancements...

The Global Physician Office Diagnostic Market Size was Valued at USD 101.25 Billion in 2023 and the Worldwide Physician Office Diagnostic Market Size is...

Octopus AIM VCT plc Final Results Octopus AIM VCT plc today announces the final results for the year ended 29 February 2024. Octopus AIM VCT plc...

Mar 29, 2022 / 03:30PM GMTOperator Good afternoon, ladies and gentlemen, and welcome to the EKF Diagnostics Holdings preliminary results investor presentations,

US market for glycated albumin tests to grow 8.7% annually. Personalized medicine in US boosts demand for tests to manage diabetes. ...

Octopus AIM VCT 2 plc Final Results Octopus AIM VCT 2 plc today announces the final results for the year ended 30 November 2023. Octopus AIM VCT 2 plc...

EKF Diagnostics Holdings PLC - Cardiff-headquartered medical diagnostics company - Trading update to December 31. Expects to report full-year revenue and adjusted earnings before interest, tax,...

19 December 2023 HARGREAVE HALE AIM VCT PLC(the “Company” or the “VCT”) Full Year Results and Notice of AGM Hargreave Hale AIM VCT plc...

Integration of Electronic Health Records (EHRs) and telehealth solutions is likely to spur the HbA1c laboratory testing market growth in the forthcoming...

The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: ---------- FireAngel Safety Technology Group PLC - developer and...

Leading Molecular Transport Medium Market players include Thermo Fisher ScientificHoldings, Inc., Becton, Dickinsonand Company, Medical Wire & Equipment,...

/PRNewswire/ -- The point-of-care diagnostics market size is estimated to grow by USD 14,645.04 million between 2022 and 2027, accelerating at a CAGR of 10.65%...

According to DelveInsight's’ estimates, the sepsis market in 7MM is expected to show good positive growth, during the forecast period (2023–2032), mainly...

/PRNewswire/ -- The

The enzyme contract manufacturing market dynamics are anticipated to change in the coming years owing to the burgeoning pharmaceutical and healthcare...

13 June 2023 HARGREAVE HALE AIM VCT PLC(the “Company”) Unaudited Interim Results The Company announces its half-year results for the six months...

Octopus AIM VCT plc Final Results Octopus AIM VCT plc today announces the final results for the year ended 28 February 2023. Octopus AIM VCT plc...

/PRNewswire/ -- The